Information for the public
NICE guidelines provide advice on the care and support that should be offered to people who use health and care services.
This information explains the advice about Crohn's disease that is set out in NICE guideline CG152.
Information about treatment with infliximab and adalimumab was added in 2016. This information is in the section drug treatment for active Crohn's disease.